Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Antihyperglycemic effects of stevioside in type 2 diabetic subjects.

Gregersen S, Jeppesen PB, Holst JJ, Hermansen K.

Metabolism. 2004 Jan;53(1):73-6.

PMID:
14681845
2.

Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.

Dupre J.

Regul Pept. 2005 Jun 15;128(2):149-57. Review. Erratum in: Regul Pept. 2006 Mar 15;134(1):67-8.

PMID:
15780434
3.

Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.

Nauck MA.

Horm Metab Res. 2004 Nov-Dec;36(11-12):852-8. Review.

PMID:
15655719
4.

Stevioside.

Geuns JM.

Phytochemistry. 2003 Nov;64(5):913-21. Review.

PMID:
14561506
5.

[Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].

Ferlito S, Volpicelli D, Del Campo F, Romano F, Modica L.

Clin Ter. 1981 May 31;97(4):333-47. Review. Italian. No abstract available.

PMID:
6113914
6.

Stevioside and related compounds - molecules of pharmaceutical promise: a critical overview.

Brahmachari G, Mandal LC, Roy R, Mondal S, Brahmachari AK.

Arch Pharm (Weinheim). 2011 Jan;344(1):5-19. doi: 10.1002/ardp.201000181. Epub 2010 Nov 25. Review.

PMID:
21213347
7.

Downstream processing of stevioside and its potential applications.

Puri M, Sharma D, Tiwari AK.

Biotechnol Adv. 2011 Nov-Dec;29(6):781-91. doi: 10.1016/j.biotechadv.2011.06.006. Epub 2011 Jun 25. Review.

PMID:
21726623
8.

Supplemental Content

Support Center